Security key
918385105
- Security type / class
- Equity / CL A
- Total 13F shares
- 3,729,500
- Total 13F value
- $2,463,558
- Share change
- +241,257
- SEC-reported price per share
- $0.66
- Number of holders
- 27
- Value change
- +$150,195
- Number of buys
- 11
- Number of sells
- 8
Report period
Q4 2022
Institutions
27
Top holders
10
VTVT full security history
Ownership snapshot
Full 13F holder table
vTv Therapeutics Inc. SEC filings
vTv Therapeutics Inc. company facts
Broader feeds
Ownership snapshot
Top reported holders of VTVT - VTV THERAPEUTICS INC - CL A (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
Ronald O Perelman
Disclosed value leader
Ronald O Perelman
Comparable rows
0/15
Latest evidence
30 Sep 2022
3/4/5
13F
Highest disclosed value: $30,482,586
15 rows are not safely comparable across share classes.
Showing 1-6 of 15 holder rows.
Quick read
Ronald O Perelman has the largest disclosed position value at $30.48M.
0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens Ronald O Perelman's linked filing trail.
Disclosed position value
Top 5
Ronald O Perelman
$30.48M
Deepa Prasad
$29.51M
Rich S. Nelson
$5.9M
Samsara BioCapital, LLC
$1.59M
VANGUARD GROUP INC
$911K
Value bars compare disclosed positions; verify each figure against the linked filing evidence.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Ronald O Perelman |
3/4/5
10%+ Owner
|
—
denominator unverified
|
$30,482,586
36,519,212 shares
|
— | 20 Dec 2021 |
| G42 Investments AI Holdings RSC Ltd. |
3/4/5
Director, 10%+ Owner
|
—
denominator unverified
|
—
10,386,274 shares
|
— | 31 May 2022 |
| Hh Sheikh Tahnoon bin Zayed S. Al-Nahyan |
3/4/5
10%+ Owner
|
—
denominator unverified
|
—
10,386,274 shares
|
— | 31 May 2022 |
| Deepa Prasad |
3/4/5
President and CEO, Director
|
—
denominator unverified
|
$29,508,879
2,498,635 shares
|
— | 19 Oct 2021 |
| Rich S. Nelson |
3/4/5
Acting Chief Executive Officer, Director
|
—
denominator unverified
|
$5,905,000
500,000 shares
|
— | 03 Mar 2022 |
| Samsara BioCapital, LLC |
13F
Company
|
—
denominator unverified
|
$1,586,000
1,635,509 shares
|
— | 30 Sep 2022 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q4 2022
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
27
Shares
3,729,500
Rows available
27
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q4 2022 vs Q3 2022 Across Filers
Q3 2022 holders
23
Q4 2022 holders
27
Holder diff
4
| Investor | Q3 2022 Shares | Q4 2022 Shares | Share Diff | Share Chg % | Q3 2022 value | Q4 2022 value | Value change | Value Chg % |
|---|